CymaBay Therapeutics, Inc.
CBAYDelisted Mar 22, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001042074
CymaBay Therapeutics, Inc. was delisted on Mar 22, 2024; its insiders filed their last Form 4 on Mar 22, 2024; 200 institutions reported holding it in 13F filings for Q4 2023, worth $2.71B in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in CymaBay Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 189
- +39 vs. Q2 2023
- Shares held
- 108.3M
- +15.4M (+16.6%) vs. Q2 2023
- Total value
- $1.61B
- +$597.9M (+58.8%) vs. Q2 2023
- New holders
- 63
- 57 more added
- Sold out
- 24
- 52 more reduced
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CBAY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 1 | $21.1K |
| Q4 2023 | 200 | $2.71B |
| Q3 2023 | 189 | $1.61B |
| Q2 2023 | 151 | $1.02B |
| Q1 2023 | 140 | $774.9M |
| Q4 2022 | 118 | $404.2M |
| Q3 2022 | 100 | $217.9M |
| Q2 2022 | 106 | $185.9M |
| Q1 2022 | 118 | $202.8M |
| Q4 2021 | 113 | $215.7M |
| Q3 2021 | 114 | $169.3M |
| Q2 2021 | 113 | $227.4M |
| Q1 2021 | 130 | $251.7M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding CymaBay Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −68,579−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −42,267−100.0% | Sold out |
| Mackenzie Financial Corp | 0 | $0 | 0.00% | −35,660−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −23,300−100.0% | Sold out |
| LVM Capital Management Ltd | 0 | $0 | 0.00% | −23,000−100.0% | Sold out |
| Blueshift Asset Management, LLC | 0 | $0 | 0.00% | −19,413−100.0% | Sold out |
| Capstone Investment Advisors, LLC | 0 | $0 | 0.00% | −19,124−100.0% | Sold out |
| Johnson Investment Counsel Inc | 0 | $0 | 0.00% | −18,000−100.0% | Sold out |
| Boulder Hill Capital Management LP | 0 | $0 | 0.00% | −17,700−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −16,517−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −7,400−100.0% | Sold out |
| Harbor Capital Advisors, Inc. | 0 | $0 | 0.00% | −4,701−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Pictet Asset Management SA | – | – | – | – | Not filed |